Anti-apoptotic mechanism of ursodeoxycholic acid (UDCA) on hypoxic cardiomyocytes

• Main Author: Noorul Izzati Hanafi (Author)
• Format: Thesis Book
• Language: English
• Published: Sungai Buloh, Selangor Universiti Teknologi MARA. Faculty of Medicine 2017
• Subjects: Bile Acids and Salts > immunology; Apoptosis; Apoptosis Regulatory Proteins; Hypoxia > physiopathology
• Online Access: Click Here to View Status and Holdings.
• Item Description: UiTM Digitized
• Physical Description: xx, 148 pages illustrations (some color), charts, 3 pages of plates 30 cm
• Bibliography: Includes bibliographical references (page 108-133)

Ursodeoxycholic acid (UDCA), the most hydrophilic bile acid is used as a therapeutic agent in liver related diseases and to eliminate hydrophobic bile acid induced apoptosis in liver. Recently, studies suggested the potential used of UDCA in treating heart related diseases. UDCA is reported cardioprotective against the development of ischemia. However, the mechanism of action in UDCA-cardioprotection is not clearly understood. Therefore, this study aimed to determine the anti-apoptotic mechanisms of UDCA on cardioprotection using an in vitro hypoxic model of neonatal rat cardiomyocytes. Rat heart from newborn (0-2 days old) was isolated for primary cell culture of cardiomyocytes. Hypoxia was induced by using C0CI2 and hypoxic chamber. Cardiomyocytes were incubated with UDCA (pre-UDCA and post-UDCA) and coincubated with FTY720 (SIP receptor agonist), PTX (Ga; inhibitor). The treated cardiomyocytes were subjected for proliferation assay (MTS assay), beating assessment assay, protein expression (aSMase and nSMase, Hif-la, caspase-3 and caspase-9, ERK and Akt), ROS generation assay and gene expression {Hif-la, smpdl, smpd2, caspase-3, caspase-9). The data were analyzed by using sample paired t-test and One-way ANOVA. MTS assay revealed that UDCA was not toxic to cardiomyocytes even at high concentration (250 urn). Results showed that C0CI2 activates Hif-la expression, reduces cell viability; reduce beating rate, upregulates nSMase protein, increases ROS production, downregulates ERK and Akt protein expression. Interestingly, pre-UDCA treatment significantly abolished the negative effects of C0CI2 on cell viability, beating rate, ROS production, ERK and Akt expression in cardiomyocytes. Treatment with PTX partially inhibits the protection of UDCA against C0CI2 negatives effects on beating rate of cardiomyocytes. Meanwhile, FTY720 showed similarity with UDCA action in downregulating smpdl gene expression and upregulates caspase-9 gene expression. In conclusion, the current data suggests that UDCA mechanism is mediated partially through Gdi-coupled receptor dependent and independent pathways in protecting cardiomyocytes against hypoxia. This study provides an insight of anti-apoptotic mechanism of UDCA on hypoxic cardiomyocytes